Company Name: MannKind Corporation    

MannKind Corporation is a biopharmaceutical company. The company’s FDA approved AFREZZA is a rapid-acting inhaled insulin designed to improve glycemic control in adult diabetics.

Ticker Symbol: MNKD (NASDAQ)

Company Website: www.mannkindcorp.com

Social Media:

MannKind Facebook

MannKind LinkedIn

MannKind Twitter

Headquarters: Valencia, California